Additional Information
- Heart Surgery Risks Leading to Trasylol Lawsuits
- Trasylol Lawsuit
has the experience
and resources to
handle complex claims involving prescription medication.
Heart Surgery Risks Leading to Trasylol Lawsuits
Since the Bayer AG drug was brought to market in 1993, it has been used in one- third of all open heart surgeries in the US. Unfortunately numerous studies have indicated that Trasylol puts such patients at a higher risk of death. An analysis of patients treated with the drug suggests that Trasylol could also increase the likelihood of serious kidney damage, congestive heart failure and strokes. Dr. Mangano, the author of a 2006 Trasylol study told “60 Minutes” that he believes Trasylol should have been taken off the market when he published his study in 2006.1
The Simmons firm has represented thousands of pharmaceutical clients and recovered more than $100 million in verdicts and settlements.* We have experience in filing a Trasylol lawsuit as well as litigating other complex medical matters. We have taken a leadership role in standing up for individuals who have been injured by dangerous or defective drugs.
If you or someone you love were injured by Trasylol, please contact our Trasylol lawyers for a free consultation. Call 1-877-318-0580 or contact us online.
* Please note that recovery results vary per client. The recovery amounts in each case reflect the specific facts of that case. Further, recovery amounts in past cases are not a guarantee of future results.